Cost may increase as much as 170% from September, but patients warned against a quick switch to Wegovy
People using the weight loss jab Mounjaro have been warned against switching to black market sellers or bulk buying after its manufacturer announced the UK will get a significant price rise this autumn.
The US pharmaceutical company Eli Lilly, which makes Mounjaro, recently announced plans to increase the price of the medication in the UK by as much as 170% from September. The move follows pressure from the US president, Donald Trump, to cut medication prices for Americans.
Eli Lilly has said the NHS will be shielded from the price rise, but with few people eligible for access through the health service, most purchase Mounjaro privately. One month’s supply of the highest dose costs about £200 through many online pharmacies and is now expected to go up.
Henry Gregg, the chief executive of the National Pharmacy Association (NPA), said the rising cost of Mounjaro had caused understandable concern to patients and pharmacies alike.
